Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

63.60
-0.1300-0.20%
Pre-market: 63.56-0.0400-0.06%06:09 EDT
Volume:9.45M
Turnover:602.09M
Market Cap:129.47B
PE:14.00
High:64.39
Open:64.07
Low:63.22
Close:63.73
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.28
T/O Rate:0.47%
Dividend:2.51
Dividend Rate:3.95%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.80
PE(LYR):18.38

Loading ...

European Shares Start August Higher on US-Iran Diplomacy Hopes

Reuters
·
Aug 03

LIVE Markets-Broadly in the Green

Reuters
·
Aug 03

Premarket Movers | Alibaba up 4%; Atkore jumps 25%; BMY up 6%; AZN down 6%; PLTR up 2%

Tiger Newspress
·
Aug 03

Movement Alert|Bristol-Myers Squibb Rises 3.74% in Pre-Market Trading, AstraZeneca Reportedly in Merger Talks That Could Create Largest-Ever Pharma Deal

Market Focus
·
Aug 03

AstraZeneca Could Want to Move Closer to U.S. Market

Dow Jones
·
Aug 03

AstraZeneca Can Hit Revenue Target on Its Own

Dow Jones
·
Aug 03

AstraZeneca Shares Seen Slipping 3% After Reported Bristol Myers Talks

Reuters
·
Aug 03

AstraZeneca Shares Down 2.75% on Tradegate

THOMSON REUTERS
·
Aug 03

LIVE MARKETS-Europe Before the Bell: Peace Deal Hopes, Again

Reuters
·
Aug 03

UK Stocks-Factors to Watch on August 3

Reuters
·
Aug 03

PRESS DIGEST-Financial Times - August 3

Reuters
·
Aug 03

Movement Alert|Bristol-Myers Squibb Rises 3.28% Overnight, AstraZeneca Reportedly in Merger Talks That Could Create Largest Pharma Deal in History

Market Focus
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger

Benzinga_recent_news
·
Aug 03

AstraZeneca Holds Talks with Bristol Myers Squibb on Pharma Megadeal- FT

THOMSON REUTERS
·
Aug 03

Bristol-Myers Squibb's Catalyst Delays May Keep Stock Range-Bound, RBC Says

MT Newswires Live
·
Aug 01

Bristol-Myers Squibb is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 31

Ratio Therapeutics Announced Closing of a $70 Million Series C Financing

Reuters
·
Jul 31

Ratio Therapeutics: Financing Included Participation from Bristol Myers Squibb, Eli Lilly and Company, Wasatch Group & More

THOMSON REUTERS
·
Jul 31